Rabavert rabies vacc w-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F1GLN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,684
Award facts
- Contract value 100% obligated
- $41,684.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,684.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on January 28, 2026, with an ultimate completion date of January 29, 2026. This delivery order, which carries no set-aside designation, represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026. The vaccine will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a critical vendor in the federal pharmaceutical supply chain with extensive experience delivering vaccines, medications, and medical supplies to government healthcare agencies. The company's established IDC vehicle with DLA demonstrates its capability to fulfill competitive federal procurement requirements and supply the comprehensive range of medical commodities needed to support military treatment facilities and federal healthcare programs globally. This rabies vaccine delivery represents one of many task orders executed under the broader pharmaceutical support contract that enables AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1GLN?
SPE2DR26F1GLN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1GLN worth?
The government has obligated $41,684 on SPE2DR26F1GLN.
Is contract SPE2DR26F1GLN an order under another contract?
Yes. SPE2DR26F1GLN is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GLN competed?
The extent of competition for SPE2DR26F1GLN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award